Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Extracorporeal membrane oxygenation (ECMO) is a lifesaving intervention for potentially reversible severe cardiac or respiratory failure. Acute kidney injury (AKI) is a common complication in this setting, often necessitating renal replacement therapy (RRT) and worsening outcomes. This study aims to assess the incidence, risk factors, and outcomes of AKI in patients receiving ECMO.
This single-centre, prospective study, conducted from 2023 to 2025, included 45 patients who underwent ECMO for more than 24 hours. Patients with end-stage renal disease (ESRD) on maintenance hemodialysis were excluded. Acute kidney injury was diagnosed and categorised according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria.
Of the 45 patients studied, 12 patients (26.66%) developed AKI, and 9 patients (75%) among them developed AKI within 24 hours of initiation of ECMO. Sepsis, inotropic support and poor cardiac function were the risk factors associated with the development of AKI. RRT was required in all 12 patients (100%), although out of the 3 (25%) recipients who survived, none had RRT dependence. Severe AKI requiring Continuous Renal Replacement Therapy (CRRT) occurred in 4 (33%) of ECMO patients. The overall mortality in the whole group was 62.22%(28/45), rising to 75% (9/12) among the patients with AKI.
AKI during ECMO support markedly increases mortality risk. Preventive strategies, early detection, and appropriate,timely management of AKI are essential to improving survival outcomes in ECMO patients.